{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:39:02Z","timestamp":1793137142559,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00264-016-3146-y","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T03:06:38Z","timestamp":1459393598000},"page":"1299-1307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies"],"prefix":"10.1007","volume":"40","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohai","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengju","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"3146_CR1","doi-asserted-by":"crossref","first-page":"179S","DOI":"10.1016\/8756-3282(95)00499-8","volume":"18","author":"DR Wasnich","year":"1996","unstructured":"Wasnich DR (1996) Vertebral fracture epidemiology. Bone 18:179S\u2013183S","journal-title":"Bone"},{"key":"3146_CR2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMra1110560","volume":"367","author":"KS Polonsky","year":"2012","unstructured":"Polonsky KS (2012) The past 200\u00a0years in diabetes. N Engl J Med 367:1332\u20131340","journal-title":"N Engl J Med"},{"key":"3146_CR3","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00125-004-1560-y","volume":"47","author":"EM Dennison","year":"2004","unstructured":"Dennison EM, Syddall HE, Aihie Sayer A, Craighead S, Phillips DI, Cooper C (2004) Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? Diabetologia 47:1963\u20131968. doi: 10.1007\/s00125-004-1560-y","journal-title":"Diabetologia"},{"key":"3146_CR4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1359\/JBMR.041219","volume":"20","author":"AV Schwartz","year":"2005","unstructured":"Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE, Shorr RI, Nevitt MC, Black DM, Cauley JA, Cummings SR, Harris TB (2005) Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res 20:596\u2013603. doi: 10.1359\/JBMR.041219","journal-title":"J Bone Miner Res"},{"key":"3146_CR5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2298\/MPNS0504147I","volume":"58","author":"J Ilic","year":"2005","unstructured":"Ilic J, Kovacev B (2005) Diabetic osteopathy. Med Pregl 58:147\u2013152","journal-title":"Med Pregl"},{"key":"3146_CR6","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","volume":"305","author":"AV Schwartz","year":"2011","unstructured":"Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM (2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184\u20132192. doi: 10.1001\/jama.2011.715","journal-title":"JAMA"},{"key":"3146_CR7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/17453678709146395","volume":"58","author":"PJ Daly","year":"1987","unstructured":"Daly PJ, Fitzgerald RH Jr, Melton LJ, Ilstrup DM (1987) Epidemiology of ankle fractures in Rochester, Minnesota. Acta Orthop Scand 58:539\u2013544","journal-title":"Acta Orthop Scand"},{"key":"3146_CR8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jbmr.5650110920","volume":"11","author":"DG Seeley","year":"1996","unstructured":"Seeley DG, Kelsey J, Jergas M, Nevitt MC (1996) Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:1347\u20131355. doi: 10.1002\/jbmr.5650110920","journal-title":"J Bone Miner Res"},{"key":"3146_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporos Int 18:427\u2013444. doi: 10.1007\/s00198-006-0253-4","journal-title":"Osteoporos Int"},{"key":"3146_CR10","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/jbmr.080323","volume":"23","author":"LJ Melton 3rd","year":"2008","unstructured":"Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S (2008) Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 23:1334\u20131342. doi: 10.1359\/jbmr.080323","journal-title":"J Bone Miner Res"},{"key":"3146_CR11","doi-asserted-by":"crossref","first-page":"A601","DOI":"10.1016\/j.jval.2015.09.2062","volume":"18","author":"C Shah","year":"2015","unstructured":"Shah C, Shah R, Kinra G, Singuru S, Naidu M, Dang A (2015) Risk of fracture in type 2 diabetes mellitus patients: meta-analysis of observational studies. Value Health 18:A601. doi: 10.1016\/j.jval.2015.09.2062","journal-title":"Value Health"},{"key":"3146_CR12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/jbmr.2118","volume":"29","author":"EJ Hothersall","year":"2014","unstructured":"Hothersall EJ, Livingstone SJ, Looker HC, Ahmed SF, Cleland S, Leese GP, Lindsay RS, McKnight J, Pearson D, Philip S, Wild SH, Colhoun HM (2014) Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland. J Bone Miner Res 29:1054\u20131060. doi: 10.1002\/jbmr.2118","journal-title":"J Bone Miner Res"},{"key":"3146_CR13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00198-014-2986-9","volume":"26","author":"D Martinez-Laguna","year":"2015","unstructured":"Martinez-Laguna D, Tebe C, Javaid MK, Nogues X, Arden NK, Cooper C, Diez-Perez A, Prieto-Alhambra D (2015) Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study. Osteoporos Int 26:827\u2013833. doi: 10.1007\/s00198-014-2986-9","journal-title":"Osteoporos Int"},{"key":"3146_CR14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2337\/dc06-1851","volume":"30","author":"LL Lipscombe","year":"2007","unstructured":"Lipscombe LL, Jamal SA, Booth GL, Hawker GA (2007) The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care 30:835\u2013841. doi: 10.2337\/dc06-1851","journal-title":"Diabetes Care"},{"key":"3146_CR15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"3146_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"RLN DerSimonian","year":"1986","unstructured":"DerSimonian RLN (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"3146_CR17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"3146_CR18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/dc12-1168","volume":"36","author":"AL Schneider","year":"2013","unstructured":"Schneider AL, Williams EK, Brancati FL, Blecker S, Coresh J, Selvin E (2013) Diabetes and risk of fracture-related hospitalization: the Atherosclerosis Risk in Communities Study. Diabetes Care 36:1153\u20131158. doi: 10.2337\/dc12-1168","journal-title":"Diabetes Care"},{"key":"3146_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11657-011-0068-6","volume":"6","author":"CC Ma","year":"2011","unstructured":"Ma CC, Burchfiel CM, Grove J, Fekedulegn D, Lu Y, Andrew ME, Willcox B, Masaki KH, Curb JD, Rodriguez BL (2011) Risk factors for fractures among Japanese-American men: The Honolulu Heart Program and Honolulu-Asia Aging Study. Arch Osteoporos 6:197\u2013207. doi: 10.1007\/s11657-011-0068-6","journal-title":"Arch Osteoporos"},{"key":"3146_CR20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00198-006-0137-7","volume":"17","author":"AH Holmberg","year":"2006","unstructured":"Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17:1065\u20131077. doi: 10.1007\/s00198-006-0137-7","journal-title":"Osteoporos Int"},{"key":"3146_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","volume":"86","author":"AV Schwartz","year":"2001","unstructured":"Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32\u201338. doi: 10.1210\/jcem.86.1.7139","journal-title":"J Clin Endocrinol Metab"},{"key":"3146_CR22","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/jc.2006-0614","volume":"91","author":"DE Bonds","year":"2006","unstructured":"Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL (2006) Risk of fracture in women with type 2 diabetes: the Women\u2019s Health Initiative Observational Study. J Clin Endocrinol Metab 91:3404\u20133410. doi: 10.1210\/jc.2006-0614","journal-title":"J Clin Endocrinol Metab"},{"key":"3146_CR23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00223-012-9591-8","volume":"90","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, Vestergaard P, Gallagher AM, van Staa TP, Cooper C, Leufkens HG, de Vries F (2012) Risk of fracture with thiazolidinediones: disease or drugs? Calcif Tissue Int 90:450\u2013457. doi: 10.1007\/s00223-012-9591-8","journal-title":"Calcif Tissue Int"},{"key":"3146_CR24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00198-006-0111-4","volume":"17","author":"WD Leslie","year":"2006","unstructured":"Leslie WD, Derksen S, Prior HJ, Lix LM, Metge C, O\u2019Neil J (2006) The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian Aboriginals and nonAboriginals. Osteoporos Int 17:1358\u20131368. doi: 10.1007\/s00198-006-0111-4","journal-title":"Osteoporos Int"},{"key":"3146_CR25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"3146_CR26","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0002-9343(97)90025-5","volume":"103","author":"PD Ross","year":"1997","unstructured":"Ross PD (1997) Clinical consequences of vertebral fractures. Am J Med 103:S30\u201340","journal-title":"Am J Med"},{"key":"3146_CR27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/aje\/kwn407","volume":"169","author":"T Wilsgaard","year":"2009","unstructured":"Wilsgaard T, Emaus N, Ahmed LA, Grimnes G, Joakimsen RM, Omsland TK, Berntsen GR (2009) Lifestyle impact on lifetime bone loss in women and men: the Tromso Study. Am J Epidemiol 169:877\u2013886. doi: 10.1093\/aje\/kwn407","journal-title":"Am J Epidemiol"},{"key":"3146_CR28","author":"K Ganeko","year":"2015","unstructured":"Ganeko K, Masaki C, Shibata Y, Mukaibo T, Kondo Y, Nakamoto T, Miyazaki T, Hosokawa R (2015) Bone aging by advanced glycation end products: a multiscale mechanical analysis. J Dent Res. doi: 10.1177\/0022034515602214","journal-title":"J Dent Res"},{"key":"3146_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2006.03.017","volume":"371","author":"GE Hein","year":"2006","unstructured":"Hein GE (2006) Glycation endproducts in osteoporosis\u2014is there a pathophysiologic importance? Clin Chim Acta 371:32\u201336. doi: 10.1016\/j.cca.2006.03.017","journal-title":"Clin Chim Acta"},{"key":"3146_CR30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","volume":"21","author":"M Saito","year":"2010","unstructured":"Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195\u2013214. doi: 10.1007\/s00198-009-1066-z","journal-title":"Osteoporos Int"},{"key":"3146_CR31","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.micinf.2004.08.004","volume":"6","author":"T Chavakis","year":"2004","unstructured":"Chavakis T, Bierhaus A, Nawroth PP (2004) RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 6:1219\u20131225. doi: 10.1016\/j.micinf.2004.08.004","journal-title":"Microbes Infect"},{"key":"3146_CR32","doi-asserted-by":"crossref","first-page":"31740","DOI":"10.1074\/jbc.274.44.31740","volume":"274","author":"T Kislinger","year":"1999","unstructured":"Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740\u201331749","journal-title":"J Biol Chem"},{"key":"3146_CR33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/er.2012-1042","volume":"36","author":"MP Gilbert","year":"2015","unstructured":"Gilbert MP, Pratley RE (2015) The impact of diabetes and diabetes medications on bone health. Endocr Rev 36:194\u2013213. doi: 10.1210\/er.2012-1042","journal-title":"Endocr Rev"},{"key":"3146_CR34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","volume":"92","author":"A Grey","year":"2007","unstructured":"Grey A, Bolland M, Gamble G, Wattie D, Horne A, Davidson J, Reid IR (2007) The peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 92:1305\u20131310","journal-title":"J Clin Endocrinol Metab"},{"key":"3146_CR35","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00198-009-1161-1","volume":"21","author":"I Kanazawa","year":"2010","unstructured":"Kanazawa I, Yamaguchi T, Yano S, Yamamoto M, Yamauchi M, Kurioka S, Sugimoto T (2010) Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus. Osteoporos Int 21:2013\u20132018. doi: 10.1007\/s00198-009-1161-1","journal-title":"Osteoporos Int"},{"key":"3146_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","volume":"68","author":"ZN Zhu","year":"2014","unstructured":"Zhu ZN, Jiang YF, Ding T (2014) Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials. Bone 68:115\u2013123. doi: 10.1016\/j.bone.2014.08.010","journal-title":"Bone"},{"key":"3146_CR37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/dmrr.1197","volume":"27","author":"S Kurra","year":"2011","unstructured":"Kurra S, Siris E (2011) Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes Metab Res Rev 27:430\u2013435. doi: 10.1002\/dmrr.1197","journal-title":"Diabetes Metab Res Rev"},{"key":"3146_CR38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2006.02.030","volume":"536","author":"AM Cortizo","year":"2006","unstructured":"Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L (2006) Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol 536:38\u201346. doi: 10.1016\/j.ejphar.2006.02.030","journal-title":"Eur J Pharmacol"},{"key":"3146_CR39","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00198-015-3123-0","volume":"26","author":"A Palermo","year":"2015","unstructured":"Palermo A, D\u2019Onofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N (2015) Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int 26:2073\u20132089. doi: 10.1007\/s00198-015-3123-0","journal-title":"Osteoporos Int"},{"key":"3146_CR40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM (2013) PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med 19:557\u2013566. doi: 10.1038\/nm.3159","journal-title":"Nat Med"},{"key":"3146_CR41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0168-8227(94)90126-0","volume":"23","author":"F Gregorio","year":"1994","unstructured":"Gregorio F, Critallini S, Santeusanio F (1994) Osteopenia associated with noninsulin-dependent diabetes mellitus: what are the cause? Diabetes Res Clin Pract 23:43\u201354","journal-title":"Diabetes Res Clin Pract"},{"key":"3146_CR42","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","volume":"289","author":"KM Thrailkill","year":"2005","unstructured":"Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289:E735\u2013745. doi: 10.1152\/ajpendo.00159.2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3146_CR43","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1210\/endo.140.4.6620","volume":"140","author":"G Maor","year":"1999","unstructured":"Maor G, Karnieli E (1999) The insulin-sensitive glucose transporter (GLUT4) is involved in early bone growth in control and diabetic mice, but is regulated through the insulin-like growth factor I receptor. Endocrinology 140:1841\u20131851. doi: 10.1210\/endo.140.4.6620","journal-title":"Endocrinology"},{"key":"3146_CR44","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto M (2015) Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength [Review]. Endocr J. doi: 10.1507\/endocrj.EJ15-0129","journal-title":"Endocr J"},{"key":"3146_CR45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1302\/0301-620X.97B1.34558","volume":"97-b","author":"GS Maier","year":"2015","unstructured":"Maier GS, Seeger JB, Horas K, Roth KE, Kurth AA, Maus U (2015) The prevalence of vitamin D deficiency in patients with vertebral fragility fractures. Bone Joint J 97-b:89\u201393. doi: 10.1302\/0301-620X.97B1.34558","journal-title":"Bone Joint J"},{"key":"3146_CR46","first-page":"868961","volume":"2015","author":"Y Obi","year":"2015","unstructured":"Obi Y, Hamano T, Isaka Y (2015) Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Dis Markers 2015:868961. doi: 10.1155\/2015\/868961","journal-title":"Dis Markers"},{"key":"3146_CR47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/PPA.S32745","volume":"6","author":"SA Abdulameer","year":"2012","unstructured":"Abdulameer SA, Sulaiman SA, Hassali MA, Subramaniam K, Sahib MN (2012) Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do? Patient Prefer Adherence 6:435\u2013448. doi: 10.2147\/PPA.S32745","journal-title":"Patient Prefer Adherence"},{"key":"3146_CR48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40520-014-0258-3","volume":"27","author":"S Gonnelli","year":"2015","unstructured":"Gonnelli S, Caffarelli C, Giordano N, Nuti R (2015) The prevention of fragility fractures in diabetic patients. Aging Clin Exp Res 27:115\u2013124. doi: 10.1007\/s40520-014-0258-3","journal-title":"Aging Clin Exp Res"},{"key":"3146_CR49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11914-015-0260-5","volume":"13","author":"L Oei","year":"2015","unstructured":"Oei L, Rivadeneira F, Zillikens MC, Oei EH (2015) Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep 13:106\u2013115. doi: 10.1007\/s11914-015-0260-5","journal-title":"Curr Osteoporos Rep"},{"key":"3146_CR50","first-page":"174186","volume":"2015","author":"TS Khan","year":"2015","unstructured":"Khan TS, Fraser LA (2015) Type 1 diabetes and osteoporosis: from molecular pathways to bone phenotype. J Osteoporos 2015:174186. doi: 10.1155\/2015\/174186","journal-title":"J Osteoporos"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-016-3146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00264-016-3146-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-016-3146-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T03:46:02Z","timestamp":1567741562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00264-016-3146-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3146"],"URL":"https:\/\/doi.org\/10.1007\/s00264-016-3146-y","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"value":"0341-2695","type":"print"},{"value":"1432-5195","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}